U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2700127001Smoking Cessation for Low-Income Pregnant WomenCompletedNo Results AvailablePregnancy|SmokingBehavioral: Cognitive-Behavioral Counseling (CBC)|Behavioral: Best Practice (BC) Controlhttps://ClinicalTrials.gov/show/NCT02211430
2700227002Oral DS107G in Moderate to Severe Atopic DermatitisRecruitingNo Results AvailableAtopic DermatitisDrug: DS107G|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02211417
2700327003Children's Sleep in the ICUEnrolling by invitationNo Results AvailableChildren Admitted to the Intensive Care Unithttps://ClinicalTrials.gov/show/NCT02211404
2700427004Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese MenCompletedNo Results AvailableObesityOther: Casein Protein|Other: Non-caloric placebohttps://ClinicalTrials.gov/show/NCT02211391
2700527005Effects of Stress on Observers and Their Subsequent Performance During High Fidelity Simulation-based Training.CompletedNo Results AvailableStressOther: Observer|Other: Hotseathttps://ClinicalTrials.gov/show/NCT02211378
2700627006Registro Campania Salute Network on HypertensionRecruitingNo Results AvailableHypertension; Heart Disease, Hypertensivehttps://ClinicalTrials.gov/show/NCT02211365
2700727007Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential HypertensionCompletedNo Results AvailableHypertensionDrug: Korean Red Ginseng Capsules|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02211352
2700827008A New Intervention for Social Skills Following Brain Injury (Version1)Active, not recruitingNo Results AvailableBrain InjuriesBehavioral: Peer tutor training|Other: Usual carehttps://ClinicalTrials.gov/show/NCT02211339
2700927009Genotype-guided Warfarin Individualized TreatmentRecruitingNo Results AvailableAtrial Fibrillation|Deep Venous ThrombosisBehavioral: Genotype-guided dosing algorithm for warfarin|Behavioral: Standard initiation dose for warfarinhttps://ClinicalTrials.gov/show/NCT02211326
2701027010Evaluation of Ureteral Stents in the Management of Stone DiseaseRecruitingNo Results AvailableUrinary Stones|Urinary Tract StonesDevice: Randomization to size 6 French soft vs. size 6 French hydrophobic ureteral stent.https://ClinicalTrials.gov/show/NCT02211313
2701127011MANAGE Automated Glucose MonitoringRecruitingNo Results AvailableICU/CCU Patients Requiring Blood Glucose MonitoringDevice: The OptiScanner|Device: YSI 2300 STAT Plusâ„¢https://ClinicalTrials.gov/show/NCT02211300
2701227012Promoting Informed Decision Making Through Advance Care PlanningNot yet recruitingNo Results AvailableDementia|Neurodegenerative DiseasesOther: 'Comfort Care at the End of Life for Persons with Dementia'|Other: Project Nurse - ACP Facilitatorhttps://ClinicalTrials.gov/show/NCT02211287
2701327013Improving Veteran Transitions From VA Community Living Centers to the CommunityNot yet recruitingNo Results AvailableAged|Frail ElderlyOther: Everyday Competence Assessment and Planning for Community Transitionshttps://ClinicalTrials.gov/show/NCT02211274
2701427014A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes MellitusRecruitingNo Results AvailableType 2 Diabetes MellitusBiological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebo|Biological: PF-06293620|Biological: Placebohttps://ClinicalTrials.gov/show/NCT02211261
2701527015Cardiovascular Autonomic Control Evaluation Through Cardiac Frequency Variability in Hypertensive PatientsCompletedNo Results AvailableHypertensionOther: Multidisciplinary assistance|Other: Conventional treatment and follow uphttps://ClinicalTrials.gov/show/NCT02211248
2701627016Continuous Glucose Monitoring in Controls With and Without Cystic FibrosisRecruitingNo Results AvailableCystic Fibrosishttps://ClinicalTrials.gov/show/NCT02211235
2701727017An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid CancerAvailableNo Results AvailableDifferentiated Thyroid CancerDrug: Lenvatinibhttps://ClinicalTrials.gov/show/NCT02211222
2701827018The APPROACH Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Chylomicronemia SyndromeRecruitingNo Results AvailableFamilial Chylomicronemia SyndromeDrug: volanesorsen|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02211209
2701927019Evidence-Based Tobacco Cessation Strategies in Patients With CancerActive, not recruitingNo Results AvailableMalignant NeoplasmBehavioral: smoking cessation intervention|Other: survey administration|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT02211196
2702027020InSpaceâ„¢ System in Comparison to Best Repair of Massive Rotator Cuff TearRecruitingNo Results AvailableRotator Cuff TearProcedure: Best Repair of torn Rotator Cuff|Device: InSpaceâ„¢ systemhttps://ClinicalTrials.gov/show/NCT02211183
2702127021Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 796 BS, low dose|Drug: BIBR 796 BS, high dose|Drug: Placebo|Drug: Lipopolysaccharidehttps://ClinicalTrials.gov/show/NCT02211170
2702227022Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 796 BS|Drug: Placebo|Other: high fat breakfasthttps://ClinicalTrials.gov/show/NCT02211157
2702327023Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 796 BS|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02211144
2702427024Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for MelanomaRecruitingNo Results AvailableCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaDrug: Talimogene Laherparepvec|Procedure: Immediate surgical resection of melanoma lesion(s)https://ClinicalTrials.gov/show/NCT02211131
2702527025Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPDRecruitingNo Results AvailableCOPD|Sedation|DexmedetomidineDrug: Intranasal dexemdetomidine (IN-DEX)https://ClinicalTrials.gov/show/NCT02211118
2702627026Registry to Compare Two Surgical Treatments for GERDRecruitingNo Results AvailableGastroEsophageal Reflux Diseasehttps://ClinicalTrials.gov/show/NCT02211105
2702727027Feasibility Study of a Home-based Physical Activity Intervention for Family Caregivers of People With Advanced CancerCompletedNo Results AvailableSelf Care|Family CaregiversBehavioral: Physical activity intervention|Other: Usual carehttps://ClinicalTrials.gov/show/NCT02211092
2702827028A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 SubstratesCompletedNo Results AvailableHealthyDrug: JNJ-54861911|Drug: Caffeine|Drug: Midazolam|Drug: Tolbutamidehttps://ClinicalTrials.gov/show/NCT02211079
2702927029TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion RecanalizationRecruitingNo Results AvailablePatients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)Drug: Clopidogrel|Drug: Ticagrelorhttps://ClinicalTrials.gov/show/NCT02211066
2703027030Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled TrialRecruitingNo Results AvailableBrain Dead Organ DonorsDrug: Levothyroxine|Drug: placebohttps://ClinicalTrials.gov/show/NCT02211053

* Görseller ve İçerik tekif hakkına sahip olabilir